To further assess whether the Gal‐3 inhibitor enhanced the anti‐PD‐L1 antibody‐mediated promotion of T‐cell cytotoxic activity, we evaluated tumor‐infiltrating lymphocytes (TILs) and their relative activation in tumor tissues derived from mice. Here, LGALS3 is linked to neoplasm.